Completed PHASE3 INTERVENTIONAL 2-arm NCT02421770

Chamaemelum Nobile 2% Versus Placebo Topic Gel to Treat Oral Lichen Planus (lichenPlanus)

Chamaemelum Nobile 2% Versus Placebo Topic Gel to Treatment Oral LichenPlanus

Sponsor: Universidad de Murcia

Interventions Chamaemelum nobile 2% placebo

Updated 5 times since 2017 Last updated: Nov 30, 2015 Started: Jan 31, 2014 Primary completion: Jan 31, 2015 Completion: Jul 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02421770, this PHASE3 trial focuses on Oral Lichen Planus and remains completed. Sponsored by Universidad de Murcia, it has been updated 5 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universidad de Murcia

Data source: Universidad de Murcia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Murcia, Spain